These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 125374)

  • 1. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum autoantibodies in hepatitis associated antigen (HAA) positive patients. A possible index of cell-mediated immunity to the associated-infective agent.
    Dudley FJ; O'Shea MJ; Sherlock S
    Clin Exp Immunol; 1973 Mar; 13(3):367-72. PubMed ID: 4349710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B antigen (Australia antigen) among residents of a Finnish institution for the mentally retarded.
    Tevaluoto-Aarnio M; Werner B; London WT
    Med Biol; 1975 Feb; 53(1):51-9. PubMed ID: 124806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune response in patients with Down's syndrome.
    Szigeti R; Révész T; Schuler D
    Acta Paediatr Acad Sci Hung; 1974; 15(1):31-9. PubMed ID: 4277396
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic parameters in Down's syndrome.
    Jacobs PF; Burdash NM; Manos JP; Duncan RC
    Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Higgins GR; Parker CE; Faust JA; Rosenfeld M
    Am J Ment Defic; 1974 Jan; 78(4):426-8. PubMed ID: 4273154
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in Down's syndrome. I. Genetic predisposition to become a carrier of the Au-SH antigen?
    Rittner C; Schwinger E; Stockhausen FG; Dufkova J
    Vox Sang; 1970; 19(3):280-7. PubMed ID: 4251110
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients.
    Hollinger FB; Goyal RK; Hersh T; Powell HC; Schulman RJ; Malnick JL
    Am J Epidemiol; 1972 Apr; 95(4):356-62. PubMed ID: 4259384
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity tests in children with Down's syndrome].
    Szigeti R; Révész T; Schuler D
    Orv Hetil; 1974 Sep; 115(38):2173-5. PubMed ID: 4277782
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies of Australia antigen carriers with and without liver diseases.
    Nielsen JO; Reinicke V; Dietrichson O; Andersen V; Thomsen M; Andersen E
    Clin Exp Immunol; 1973 Sep; 15(1):9-16. PubMed ID: 4587828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T and B lymphocytes in patients with Down's syndrome.
    Reiser K; Whitcomb C; Robinson K; MacKenzie MR
    Am J Ment Defic; 1976 May; 80(6):613-9. PubMed ID: 134638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Shiono H; Kadowaki J; Fujiwara T; Nakao T
    Clin Pediatr (Phila); 1975 Dec; 14(12):1150-4. PubMed ID: 127683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescence and radioimmunoassay for Australia antigen.
    Millman I; Coyne VZ; Coller JA
    Am J Med Technol; 1972 Sep; 38(9):355-65. PubMed ID: 4116742
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal serum immunoglobulin levels in Down's syndrome patients.
    Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
    Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels.
    Kanavin O; Scott H; Fausa O; Ek J; Gaarder PI; Brandtzaeg P
    Acta Med Scand; 1988; 224(5):473-7. PubMed ID: 2974234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.